Internal Medicine · Flushing, NY
NPI
1033317888
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
147-17 Union Tpke
Flushing, NY, 11367
Phone (718) 275-6968
Medicare paid, 2024
$1,788
101 services
Medicare patients, 2024
19
Average age 75
Drug cost, 2024
$559K
1,392 prescriptions
Company payments, 2025
$216
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lev Aminov was code 99213 (office e&m - established), 13 times for 12 patients. In total Lev Aminov billed 101 services in 25 codes, and Medicare paid $1,788.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 13 | 12 | $15.93 | $207 |
By year: 2022 $38K for 1,461 services; 2023 $38K for 1,310 services; 2024 $1,788 for 101 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 110 | 41 | $8.40 | $924 |
| 82962 Clinical Chemistry | 46 | 23 | $3.21 | $148 |
| 83037 Blood Count | 44 | 22 | $9.52 | $419 |
| 80061 Clinical Chemistry | 42 | 24 | $13.12 | $551 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 14 | 14 | $17.69 | $248 |
Medicare prescription drug claims, 2024
In 2024, the drug Lev Aminov prescribed most often to Medicare patients was Edarbi (Azilsartan Medoxomil), with 59 prescriptions and refills. In total Lev Aminov wrote 1,392 Medicare prescriptions that cost $559K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Edarbi Azilsartan Medoxomil | 59 | 59 | 14 | $14K |
| Amlodipine Besylate Generic | 48 | 54 | 18 | $110 |
| Linzess Linaclotide | 47 | 47 | 16 | $25K |
| Qbrexza Glycopyrronium Tosylate | 45 | 45 | 14 | $28K |
| Vascepa Icosapent Ethyl | 42 | 42 | 15 | $15K |
| Metoprolol Succinate Generic | 42 | 50 | 16 | $191 |
| Farxiga Dapagliflozin Propanediol | 40 | 40 | 16 | $22K |
| Diclofenac Potassium Generic | 34 | 34 | 13 | $51K |
| Rosuvastatin Calcium Generic | 32 | 38 | 15 | $174 |
| Zenpep Lipase/Protease/Amylase | 32 | 32 | 14 | $57K |
| Nexium Esomeprazole Magnesium | 28 | 28 | Under 11 | $7,023 |
| Eliquis Apixaban | 27 | 27 | Under 11 | $17K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 26 | 26 | Under 11 | $16K |
| Cycloset Bromocriptine Mesylate | 24 | 24 | 11 | $23K |
| Atorvastatin Calcium Generic | 24 | 36 | Under 11 | $98.05 |
Brand drugs: 709 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lev Aminov $216 ($216 in general payments such as food, travel and fees) from 2 companies. The largest payer was Smith+Nephew, Inc. with $116.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.